Patents by Inventor Anjaneyulu S. Tadepalli

Anjaneyulu S. Tadepalli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-hypertensive tetralins
    Patent number: 5405872
    Abstract: This invention relates to tetralin derivatives useful in medicine for the treatment of hypertension, to the synthesis of the compounds, to the pharmaceutical formulations containing the compounds and the use of the compounds in medical practice.
    Type: Grant
    Filed: March 22, 1993
    Date of Patent: April 11, 1995
    Assignee: Burroughs Wellcome Co.
    Inventors: John D. McDermed, Kevin P. Hurley, Vincent H. Chang, Anjaneyulu S. Tadepalli
  • Anti-hypertensive sulfonanilides
    Patent number: 5194450
    Abstract: The present invention is concerned with compounds of formula (I) ##STR1## wherein R.sup.1 is hydrogen or C.sub.1-4 alkoxy;R.sub.2 is carbonyl, hydroxymethylene, or methylene; andR.sub.3 is hydrogen or hydroxy;and salts thereof, provided that when R.sub.1 is hydrogen and R.sub.2 is carbonyl, R.sub.3 is not hydroxy, with processes for preparing same and with their use in medicine for the treatment of hypertension.
    Type: Grant
    Filed: October 28, 1991
    Date of Patent: March 16, 1993
    Assignee: Burroughs Wellcome Co.
    Inventors: John D. McDermed, Anjaneyulu S. Tadepalli, Vincent H. Chang, Kevin P. Hurley, Harold S. Freeman
  • Method of treating pulmonary hypertension with benzidine prostaglandins
    Patent number: 5153222
    Abstract: The present invention is concerned with methods for the prophylaxis, treatment and diagnosis of pulmonary hypertension which comprise the administrative of an effective amount of a compound of formula (I) ##STR1## wherein a is an integer of from 1 to 3; X and Y, which may be the same or different, are selected from --O-- and --CH.sub.2 --;R is --(CH.sub.2).sub.5 R.sup.1 wherein R.sup.1 is hydrogen or methyl, or R is cyclohexyl, orR is --CH(CH.sub.3)CH.sub.2 C.tbd.CCH.sub.3 ; andthe dotted line represents an optional double bond;or of a physiologically acceptable salt or acid derivative thereof.Medicaments and diagnostic aids for use in the methods of the invention are also within the scope of the invention.
    Type: Grant
    Filed: June 14, 1991
    Date of Patent: October 6, 1992
    Assignee: Burroughs Wellcome Co.
    Inventors: Anjaneyulu S. Tadepalli, Walker A. Long, James W. Crow, Kenneth B. Klein
  • Antihypertensive sulfonanilides
    Patent number: 5102914
    Abstract: The present invention is concerned with compounds of formula (I) ##STR1## wherein R.sub.1 is hydrogen;R.sub.2 is carbonyl; andR.sub.3 is hydroxy;and salts thereof, with processes for preparing same and with their use in medicine for the treatment of hypertension.
    Type: Grant
    Filed: December 18, 1989
    Date of Patent: April 7, 1992
    Assignee: Burroughs Wellcome Co.
    Inventors: John D. McDermed, Anjaneyulu S. Tadepalli, Vincent H. Chang, Kevin P. Hurley
  • Methods of treating pulmonary hypertension
    Patent number: 5028628
    Abstract: The present invention is concerned with methods for the treatment and diagnosis of pulmonary hypertension which comprise the administration of an effective amount of a compound of formula (I) ##STR1## wherein X is hydrogen or methyl;Y is --O-- or --CH.sub.2 --;R is --C(R.sup.1)(R.sup.2)CH.sub.2 CH.sub.2 CH.sub.2 CH.sub.3 wherein R.sup.1 and R.sup.2, which may be the same or different, are selected from hydrogen and halogen; andthe dotted line represents an optional double bond; andpharmaceutically acceptable salts and acid derivatives thereof.Medicaments and diagnostic aids for use in the methods of the invention are also within the scope of the invention.
    Type: Grant
    Filed: October 13, 1989
    Date of Patent: July 2, 1991
    Assignee: Burroughs Wellcome Co.
    Inventors: Anjaneyulu S. Tadepalli, Brendan J. R. Whittle